MaxWell Biosystems: Funding, Investors & Team (Sep 2026)
MaxWell Biosystems provides solutions to advance basic neuroscience research and accelerate preclinical drug discovery. Its product MaxOne, electrophysiology platform for recording and stimulating electrogenic cells in vitro. It is a CMOS-based high-density microelectrode array with 26,400 electrodes, 1024 low-noise readout channels, and 32 stimulation channels. It allows extracting single cell and network parameters that facilitate phenotypic screening and drug toxicity/efficacy testing.
MaxWell Biosystems has raised $4.1M across 2 funding rounds on record, the most recent a Debt Financing of $100k announced in Dec 2021.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
MaxWell Biosystems Company Profile and Key Stats
Latest funding round on record: Dec 2021.
MaxWell Biosystems Funding Rounds
MaxWell Biosystems raised $4.0M in an undisclosed round announced in Dec 2020.
1 years later, a Debt Financing of $100k was announced in Dec 2021.
MaxWell Biosystems Founders and Leadership Team
Contact details for the MaxWell Biosystems team: 1 of 1 has an email address on file.
Start 14-day free trial →MaxWell Biosystems Funding Compared to Other Biotechnology Startups
MaxWell Biosystems' latest round of $100k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like MaxWell Biosystems in Biotechnology and Basel
Companies Similar to MaxWell Biosystems
Adaptyv Biosystems developing a protein engineering platform using cell-free synthetic biology and…
At Immitra Bio, we are developing a unique genetic medicine platform that combines two of the most powerful…
compliag is providing agile solutions for regulated industries, including the licencing, manufacturing and…
MoonLake Immunotherapeutics is a biopharmaceutical company in the clinical stage that is developing new…
Isospec Analytics SA is a life science company that aims at simplifying molecular identification. We are…
Cria Technologies reinvents cold-chain transport with high-vacuum insulation technology that offers…
Precise Health is a phage therapy platform that specialises in improving and treating bacterial infections to…
AC Immune is a biopharmaceutical company based in Switzerland that is currently in the clinical stage. They…
AlveoliX provides in-vitro solutions based on proprietary and unique organ-on-chip technologies aimed at…
Combioxin SA is clinical-stage biotech company developing innovative anti-virulence drugs to treat severe…
MindMaze is a digital neurotherapeutic platform that provides digital assessments and therapeutics to treat…
Neurosoft Bioelectronics is developing next-generation soft implantable electrodes to interface with the…
MaxWell Biosystems Funding FAQs
What does MaxWell Biosystems do?
MaxWell Biosystems provides solutions to advance basic neuroscience research and accelerate preclinical drug discovery. Its product MaxOne, electrophysiology platform for recording and stimulating electrogenic cells in vitro. It is a CMOS-based high-density microelectrode array with 26,400 electrodes, 1024 low-noise readout channels, and 32 stimulation channels. It allows extracting single cell and network parameters that facilitate phenotypic screening and drug toxicity/efficacy testing.
How much funding has MaxWell Biosystems raised?
MaxWell Biosystems has raised $4.1M across 2 rounds on record. The most recent is a Debt Financing of $100k announced in Dec 2021.
When did MaxWell Biosystems last raise funding?
MaxWell Biosystems' most recent funding round on record is a Debt Financing of $100k, announced in Dec 2021.
Who is the CEO of MaxWell Biosystems?
Urs Frey is listed as CEO at MaxWell Biosystems.
Where is MaxWell Biosystems headquartered?
MaxWell Biosystems is based in Basel, Basel-Stadt, Switzerland.
How many employees does MaxWell Biosystems have?
MaxWell Biosystems is in the 11-50 employee band.
How does MaxWell Biosystems' funding compare to other Biotechnology startups?
MaxWell Biosystems' latest round of $100k is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's MaxWell Biosystems Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for MaxWell Biosystems is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.